Shaping Outcomes for Future-Focused Sustainability

Following a significant name change from Cepsa to Moeve, Alfredo Lopez, Sustainability Director at Moeve Chemicals, has taken on a central role in shaping the company’s chemical business unit sustainability outlook amid a rapidly changing landscape. As Moeve boosts its strategy, pursuing new models for circularity, decarbonization, and cross-industry collaboration, Lopez combines personal conviction with strategic vision to lead teams through transformation. In this CHEManager Leaders & Motivators interview, he shares how formative experiences inspire practical action, why partnerships and innovation are at the heart of Moeve Chemicals’ next chapter, and what it means to drive meaningful progress and resilience in today’s global chemical sector.
CHEManager: Moeve has emerged out of a major transformation from Cepsa. How has this transition shaped your sustainability ambitions at Moeve Chemicals and the company’s renewed commitment to climate leadership?
Alfredo Lopez: Moeve Group’s ambition and strategy have strengthened our understanding of stakeholder needs within Moeve Chemicals. Today, both the Group and the Chemicals business are at the forefront of the energy transition. Each business unit is channeling resources toward the development of green molecules, with the goal of delivering sustainable products and services tailored to our customers’ needs.
We see a unique opportunity to lead by example, acting ahead of our peers and before regulatory pressures or deadlines take effect.
Read more with free registration
Register now for free and get full access to all exclusive articles from chemanager-online.com. With our newsletter we regularly send you top news from the chemistry industry as well as the latest e-issue.
most read

20 Years of CHEManager International
Incredible but true: CHEManager International is celebrating its 20th anniversary!

Lead or Lag: Europe’s AI Materials Race
How AI and Robotics are reshaping the race for materials discovery.

Pharma 4.0 – the Key Enabler for Successful Digital Transformation in Pharma
Part 1: Building a Business Case for Pharma 4.0

US Tariffs Fatal for European Pharma
Trump's tariff policy is a considerable burden and a break with previous practice.

Relocation of Chemicals Production Footprint in Full Swing
A new Horváth study based on interviews with CxOs of Europe’s top chemical corporations reveals: The majority of board members expects no or only weak growth for the current year.











